Literature DB >> 13887635

Studies of smallpox antibody levels of sera from samples of the vaccinated adult population of Madras.

A W DOWNIE, T L HOBDAY, L ST VINCENT, C H KEMPE.   

Abstract

In view of the endemicity of smallpox in Madras and the poor take rate on revaccination with the lymph in current use, it was felt that the immunity of the general adult population might be relatively low. In an attempt to obtain some measure of this, sera were obtained from over 300 adults in Madras for the estimation of serum antibody. The results of neutralization tests against variola virus made on these sera showed that about 10% of those who had good scars from infant vaccination showed little or no antibody. A comparison of the antibody titres of adult sera showing good antibody levels when used undiluted was made with that of sera from smallpox convalescents. The antibody level in the latter sera was 20-100 times that of the sera of adult persons who showed good vaccination scars.

Entities:  

Keywords:  SMALLPOX/immunology

Mesh:

Substances:

Year:  1961        PMID: 13887635      PMCID: PMC2555531     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  An agar-gel precipitation test for the laboratory diagnosis of smallpox.

Authors:  K R DUMBELL; M NIZAMUDDIN
Journal:  Lancet       Date:  1959-05-02       Impact factor: 79.321

  1 in total
  3 in total

1.  Assay of neutralizing antibody against variola virus by the degree of focus reduction on HeLa cell cultures and its application to revaccination with smallpox vaccines of various potencies.

Authors:  T Kitamura; N Shinjo
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

2.  Smallpox vaccination by intradermal jet injection. 2. Cutaneous and serological responses to primary vaccination in children.

Authors:  R R Roberto; H Wulff; J D Millar
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

Review 3.  ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine.

Authors:  Richard N Greenberg; Jeffrey S Kennedy
Journal:  Expert Opin Investig Drugs       Date:  2008-04       Impact factor: 6.498

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.